These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21547892)

  • 1. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.
    Meune C; Avouac J; Airò P; Beretta L; Dieudé P; Wahbi K; Caramaschi P; Tiev K; Cappelli S; Diot E; Vacca A; Cracowski JL; Sibilia J; Kahan A; Matucci-Cerinic M; Allanore Y
    Arthritis Rheum; 2011 Sep; 63(9):2790-6. PubMed ID: 21547892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.
    Valerio CJ; Schreiber BE; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheum; 2013 Apr; 65(4):1074-84. PubMed ID: 23280155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.
    Codullo V; Caporali R; Cuomo G; Ghio S; D'Alto M; Fusetti C; Borgogno E; Montecucco C; Valentini G
    Arthritis Rheum; 2013 Sep; 65(9):2403-11. PubMed ID: 23754201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
    Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
    Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis.
    Marie I; Gourcerol G; Leroi AM; Ménard JF; Levesque H; Ducrotté P
    Arthritis Rheum; 2012 Jul; 64(7):2346-55. PubMed ID: 22231388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
    Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
    Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
    Fransen J; Popa-Diaconu D; Hesselstrand R; Carreira P; Valentini G; Beretta L; Airo P; Inanc M; Ullman S; Balbir-Gurman A; Sierakowski S; Allanore Y; Czirjak L; Riccieri V; Giacomelli R; Gabrielli A; Riemekasten G; Matucci-Cerinic M; Farge D; Hunzelmann N; Van den Hoogen FH; Vonk MC
    Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
    Chang B; Schachna L; White B; Wigley FM; Wise RA
    J Rheumatol; 2006 Feb; 33(2):269-74. PubMed ID: 16465657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire.
    Chung L; Chen H; Khanna D; Steen VD
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):454-63. PubMed ID: 23042670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma.
    Tiev KP; Hua-Huy T; Kettaneh A; Allanore Y; Le-Dong NN; Duong-Quy S; Cabane J; Dinh-Xuan AT
    Thorax; 2012 Feb; 67(2):157-63. PubMed ID: 22026971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.
    Hagger D; Condliffe R; Woodhouse N; Elliot CA; Armstrong IJ; Davies C; Hill C; Akil M; Wild JM; Kiely DG
    Rheumatology (Oxford); 2009 Sep; 48(9):1137-42. PubMed ID: 19605369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.